A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved
Open accessThe DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Abstract
The escalation of life expectancy is accompanied by an increase in the prevalence of age-related conditions, such as sarcopenia. Sarcopenia, a muscle condition defined by low muscle strength, muscle quality or quantity, and physical performance, has a high prevalence among the elderly and is associated to increased mortality. The neuromuscular system has been emerging as a key contributor to sarcopenia pathogenesis. Indeed, the age-related degeneration of the neuromuscular junction (NMJ) function and structure may contribute to the loss of muscle strength and ultimately to the loss of muscle mass that characterize sarcopenia. The present mini-review discusses important signaling pathways involved in the function and maintenance of the NMJ, giving emphasis to the ones that might contribute to sarcopenia pathogenesis. Some conceivable biomarkers, such as C-terminal agrin fragment (CAF) and brain-derived neurotrophic factor (BDNF), and therapeutic targets, namely acetylcholine and calcitonin gene-related peptide (CGRP), can be retrieved, making way to future studies to validate their clinical use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pathophysiology of this condition involves a complex interplay between muscle, adipose tissue, hormonal changes, inflammation, oxidative stress and lifestyle factors, among others.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [49]
In the citing paper
“Neuromuscular function impairment could also contribute to the development of sarcopenia via reduction in the number of active motor units, altered neuromuscular junction activity, reduced activation and innervation of muscle fibres, and impaired excitation–contraction coupling49.”
From Sarcopenic obesity in older adults: a clinical overview (2024) · cites this paper as [49]
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Longitudinal study of muscle strength, quality, and adipose tissue infiltration
Delmonico, M. J., Harris, T. B., Visser, M., Park, S. W., Conroy, M. B., Velasquez-Mieyer, P., Boudreau, R., Manini, T. M., Nevitt, M., Newman, A. B., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28047 · Cited by 1,446 · cited 1×
“Indeed, in older people, the loss of muscle strength is significantly more rapid than the loss of muscle mass, and maintaining or gaining muscle mass does not avert the aging-related decrease in muscle strength [12].”
BackgroundMitchell, W. K., Williams, J., Atherton, P., Larvin, M., Lund, J., & Narici, M. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00260 · Cited by 1,377
Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis
Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J.-Y., & Bruyère, O. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169548 · Cited by 1,272
Geriatric muscle stem cells switch reversible quiescence into senescence
Sousa-Victor, P., Gutarra, S., García-Prat, L., Rodriguez-Ubreva, J., Ortet, L., Ruiz-Bonilla, V., Jardí, M., Ballestar, E., González, S., Serrano, A. L., et al. (2014) · Nature · doi:10.1038/nature13013 · Cited by 1,010
Voluntary exercise induces a BDNF-mediated mechanism that promotes neuroplasticity
Gómez-Pinilla, F., Ying, Z., Roy, R. R., Molteni, R., & Edgerton, V. R. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00152.2002 · Cited by 724
Matthews, V. B., Åström, M.-B., Chan, M. H. S., Bruce, C. R., Krabbe, K. S., Prelovsek, O., Åkerström, T., Yfanti, C., Broholm, C., Mortensen, O. H., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1364-1 · Cited by 722
Research works printed but not linked: 1
- World Health Organization. Decade of healthy ageing: baseline report. Summary. Geneva: World Health Organization; 2021.
Cited by
Sarcopenic obesity in older adults: a clinical overview
Prado, C. M., Batsis, J. A., Donini, L. M., Gonzalez, M. C., & Siervo, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00943-z · Cited by 355
“…and social factors, and mental stress), age-related changes in body composition 47 , hormonal imbalances 48 , declining neuromuscular function 49 , increased inflammation and oxidative stress 50 , reduced activity of muscle satellite cells 51 , altered energy metabolism, and impaired…”
Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle–Brain Axis
Arosio, B., Calvani, R., Ferri, E., Coelho-Junior, H. J., Carandina, A., Campanelli, F., Ghiglieri, V., Marzetti, E., & Picca, A. (2023) · Nutrients · doi:10.3390/nu15081853 · Cited by 165
Dowling, P., Gargan, S., Swandulla, D., & Ohlendieck, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032415 · Cited by 109
Sarcopenia and nervous system disorders
Yang, J., Jiang, F., Yang, M. J., & Chen, Z. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11268-8 · Cited by 85
C‐terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review
Monti, E., Sarto, F., Sartori, R., Zanchettin, G., Löfler, S., Kern, H., Narici, M. V., & Zampieri, S. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13189 · Cited by 73
Metadata
- Authors
- Moreira-Pais, A., Ferreira, R., Oliveira, P. A., & Duarte, J. A.
- Affiliations
- University of Aveiro (PT)
- University of Trás-os-Montes and Alto Douro (PT)
- Universidade do Porto (PT)
- Venue
- GeroScience
- Published
- 2022-01-04
- Volume
- 44
- Issue
- 3
- Pages
- 1199-1213
- ISSN
- 2152-4041 (ISSN-L)
- 2509-2715
- 2509-2723
- PMC
- PMC9213593
- OpenAlex
- W4206480001
- Cited by
- 74
- References
- 124
- Citations by year
- 2026: 23 · 2025: 19 · 2024: 17 · 2023: 10 · 2022: 5
- FWCI
- 7.89
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- GeroScience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
- Keywords
- sarcopenia, neuromuscular junction, neuromuscular junction degeneration, signaling pathways, aging, muscle strength, muscle mass loss, brain-derived neurotrophic factor, acetylcholine, calcitonin gene-related peptide, biomarkers, therapeutic target
- MeSH terms
- Aged, Aging, Humans, Neuromuscular Junction, Signal Transduction, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved. https://app.cochat.ai/papers/10.1007/s11357-021-00510-2
- The paper
- Moreira-Pais, A., Ferreira, R., Oliveira, P. A., & Duarte, J. A. (2022). A neuromuscular perspective of sarcopenia pathogenesis: deciphering the signaling pathways involved. GeroScience. https://doi.org/10.1007/s11357-021-00510-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.